Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease

Human Immunology

Volumn 75, Issue 12, 2014, Pages 1197-1202

  Catarino, Sandra Jeremias dos Santos ^a   Boldt, Angelica Beate Winter ^a   Beltrame, Marcia Holsbach ^a   Nisihara, Renato Mitsunori ^a   Schafranski, Marcelo Derbli ^b   de Messias Reason, Iara Jose ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

Author keywords

Haplotype specific genotyping; MASP2; Polymorphism; Rheumatic fever; Rheumatic heart disease

Indexed keywords

MASP2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MASP2 PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BRAZILIAN; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HEART INJURY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MASP2 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTAKE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; BLOOD; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; YOUNG ADULT;

ADOLESCENT; ADULT; BASE SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84927512768     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.10.003     Document Type: Article

References (39)

1. Chang C. Cutting edge issues in rheumatic fever. Clin Rev Allergy Immunol 2011, 1-25.
2. Burke R.J., Chang C. Diagnostic criteria of acute rheumatic fever. Autoimmun Rev 2014, 13:503-507.
3. Guilherme L., Kohler K., Kalil J. Rheumatic heart disease: mediation by complex immune events. Adv Clin Chem 2011, 53:31-50.
4. Tibazarwa K., JA V., Mayosi B. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008, 94:1534-1540.
5. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5:685-694.
6. Kumar R.K., Tandon R. Rheumatic fever & rheumatic heart disease: the last 50years. Indian J Med Res 2013, 137:643-658.
7. Barbosa P., Muller R., Latado A., Achutti A., Ramos A., Weksler C. Diretrizes brasileiras para o diagnóstico, tratamento e prevenção da febre reumática. Arq Bras Cardiol 2009, 93:1-18.
8. Mayilyan K.R. Complement genetics, deficiencies, and disease associations. Protein Cell 2012, 3:487-496.
9. Stäger S., Alexander J., Kirby A.C., Botto M., Van Rooijen N., Smith D.F., et al. Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 2003, 9:1287-1292.
10. Degn S.E., Jensenius J.C., Thiel S. Disease-causing mutations in genes of the complement system. Am J Hum Genet 2011, 88:689-705.
11. Matsushita M., Endo Y., Fujita T. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication. Arch Immunol Ther Exp (Warsz) 2013, 61:273-283.
12. Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T., Jensenius J.C., et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 1999, 162:3481-3490.
13. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 2007, 44:3875-3888.
14. Laursen I., Thielens N., Christiansen M., Houen G. MASP interactions with plasma-derived MBL. Mol Immunol 2012, 52:79-87.
15. Stengaard-Pedersen K., Thiel S., Gadjeva M., Møller-Kristensen M., Sørensen R., Jensen L.T., et al. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med 2003, 349:554-560.
16. Thiel S., Steffensen R., Christensen I.J., Ip W.K., Lau Y.L., Reason I.J.M., et al. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun 2007, 8:154-163.
17. Thiel S., Kolev M., Degn S., Steffensen R., Hansen A.G., Ruseva M., et al. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J Immunol 2009, 182:2939-2947.
18. Boldt A.B.W., Grisbach C., Steffensen R., Thiel S., Kun J.F.J., Jensenius J.C., et al. Multiplex sequence-specific polymerase chain reaction reveals new MASP2 haplotypes associated with MASP-2 and MAp19 serum levels. Hum Immunol 2011, 72:753-760.
19. Boldt A.B.W., Goeldner I., Stahlke E.R.S., Thiel S., Jensenius J.C., de Messias-Reason I.J.T. Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 exon 5. PLoS One 2013, 8:e69054.
20. Tulio S., Faucz F.R., Werneck R.I., Olandoski M., Alexandre R.B., Boldt A.B.W., et al. MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. Hum Immunol 2011, 72:912-915.
21. Holmberg V., Onkamo P., Lahtela E., Lahermo P., Bedu-Addo G., Mockenhaupt F.P., et al. Mutations of complement lectin pathway genes MBL2 and MASP2 associated with placental malaria. Malar J 2012, 11:61.
22. De Rooij B.-J.F., van Hoek B., ten Hove W.R., Roos A., Bouwman L.H., Schaapherder A.F., et al. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology 2010, 52:1100-1110.
23. Boldt A.B.W., Luz P.R., Messias-Reason I.J.T. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol 2011, 140:63-70.
24. Goeldner I., Skare T., Boldt A.B.W., Nass F.R., Messias-Reason I.J., Utiyama S.R. Association of MASP-2 levels and MASP2 gene polymorphisms with rheumatoid arthritis in patients and their relatives. PLoS One 2014, 9:e90979.
25. Dajani A.S., Ayoub E., Bierman F.Z., Bisno A.L., Denny F.W., Durack D.T., et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. JAMA 1992, 268:2069-2073.
26. Schafranski M.D., Pereira Ferrari L., Scherner D., Torres R., de Messias-Reason I.J. Functional MASP2 gene polymorphism in patients with history of rheumatic fever. Hum Immunol 2008, 69:41-44.
27. Excoffier L, Lischer HEL. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010;10:564-7.
28. Guilherme L, Kalil J. Rheumatic heart disease: molecules involved in valve tissue inflammation leading to the autoimmune process and anti-S. pyogenes vaccine. Front Immunol 2013;4:352.
29. Guilherme L., Köhler K.F., Kalil J. Rheumatic heart disease: genes, inflammation and autoimmunity. Rheumatol Curr Res 2012, S4(001):1-5.
30. Boldt A.B.W., Goeldner I., De Messias-Reason I.J.T. Relevance of the lectin pathway of complement in rheumatic diseases. Adv Clin Chem 2012, 56:105-153.
31. Ramasawmy R, Spina GS, Fae KC, Pereira AC, Nisihara R, Messias Reason IJ, et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin Vaccine Immunol 2008;15:932-6.
32. Schafranski M.D., Pereira Ferrari L., Scherner D., Torres R., Jensenius J.C., de Messias-Reason I.J. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol 2008, 45:3827-3831.
33. Zhang M., Hou Y.J., Cavusoglu E., Lee D.C., Steffensen R., Yang L., et al. MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans. Int J Cardiol 2013, 166:499-504.
34. Zehnder A., Fisch U., Hirt A., Niggli F.K., Simon A., Ozsahin H., et al. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2). Pediatr Blood Cancer 2009, 53:53-57.
35. Schafranski M.D., Stier A., Nisihara R., Messias-Reason I.J.T. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 2004, 138:521-525.
36. Messias Reason I.J., Schafranski M.D., Jensenius J.C., Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol 2006, 67:991-998.
37. Messias-Reason I.J., Schafranski M.D., Kremsner P.G., Kun J.F.J. Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol 2009, 157:395-399.
38. McLean B., Oudit G.Y. Role of autoimmunity in heart disease: is Chagas heart disease the definitive proof?. Can J Cardiol 2014, 30:267-269.
39. Nebert D.W. Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypes. Hum Mutat 2002, 20:463-472.